UY34895A - STABILIZED FORMULATIONS OF ETANERCEPT - Google Patents

STABILIZED FORMULATIONS OF ETANERCEPT

Info

Publication number
UY34895A
UY34895A UY34895A UY34895A UY34895A UY 34895 A UY34895 A UY 34895A UY 34895 A UY34895 A UY 34895A UY 34895 A UY34895 A UY 34895A UY 34895 A UY34895 A UY 34895A
Authority
UY
Uruguay
Prior art keywords
etanercept
stabilized formulations
long
pharmaceutical compositions
including those
Prior art date
Application number
UY34895A
Other languages
Spanish (es)
Inventor
Douglas Farrar; Longmont
Alan Herman; Camarillo
Mark Manning; Johnstown
Brian Murphy; Fort Collins
Original Assignee
Coherus Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coherus Biosciences Inc filed Critical Coherus Biosciences Inc
Publication of UY34895A publication Critical patent/UY34895A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composiciones farmacéuticas acuosas estabilizadas de etanercept adecuadas para el almacenamiento a largo plazo de etanercept, incluyendo aquellas qu e proporcionan una reducción sustancial de las partículas menores que las visibles.Aqueous stabilized pharmaceutical compositions of etanercept suitable for long-term storage of etanercept, including those that provide a substantial reduction in particles smaller than the visible ones.

UY34895A 2012-07-09 2013-07-08 STABILIZED FORMULATIONS OF ETANERCEPT UY34895A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261669480P 2012-07-09 2012-07-09
US201361770429P 2013-02-28 2013-02-28

Publications (1)

Publication Number Publication Date
UY34895A true UY34895A (en) 2014-02-28

Family

ID=50691535

Family Applications (1)

Application Number Title Priority Date Filing Date
UY34895A UY34895A (en) 2012-07-09 2013-07-08 STABILIZED FORMULATIONS OF ETANERCEPT

Country Status (2)

Country Link
AR (1) AR091707A1 (en)
UY (1) UY34895A (en)

Also Published As

Publication number Publication date
AR091707A1 (en) 2015-02-25

Similar Documents

Publication Publication Date Title
ECSP21072161A (en) LINACLOTIDE DELAYED RELEASE COMPOSITIONS
ECSP15013227A (en) STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB
ECSP15004752A (en) ETANERCEPT FORMULATIONS THAT SHOW A MARKED REDUCTION IN THE AMOUNT OF SUBVISIBLE PARTICLES
AR088379A1 (en) FORMULATIONS OF ETANERCEPT STABILIZED WITH METAL IONS
CL2016002772A1 (en) Fast-acting insulin compositions
CL2014003136A1 (en) New diazaespirocicloalcanos and azaespirocicloalcanos; Pharmaceutical composition that contains them and uses.
CL2014002258A1 (en) Antibodies directed against matrix 9 metalloproteinases (mmp9 gelatinase b); pharmaceutical composition that contains it; and its uses
BR112015023417A2 (en) heterocyclic compounds and their uses
AR093645A1 (en) A STABILIZED FORMULATION OF PEMETREXED
PH12016500720A1 (en) Stable formulation of insulin glulisine
CL2015002060A1 (en) Compounds
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
CO7061076A2 (en) Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative
WO2014153009A3 (en) Thiosaccharide mucolytic agents
CL2017000394A1 (en) Composition containing cineole for nasal administration
CO6920289A2 (en) Topical ophthalmic pharmaceutical composition containing regorafenib.
CL2014001862A1 (en) Compounds derived from substituted moropholinyl, useful as mogat-2 inhibitors; pharmaceutical composition that includes them; use in the treatment of hypertriglyceridemia.
CO2017007316A2 (en) Pharmaceutical formulation
PE20150167A1 (en) (R) -NIFURATEL, ITS USE FOR THE TREATMENT OF INFECTIONS AND SYNTHESIS OF (R) AND (S) -NIFURATEL
BR112015006692A2 (en) nanodispersion formulation, method for administering an ethanol free taxine liquid nanodispersion formulation to an individual, and, kit.
BR112013023575A2 (en) “octahydrothienoquinoline derivative, pharmaceutical composition comprising the derivative, and use thereof”
BR112017001888A2 (en) biological formulations for intravesical instillation
CL2014000595A1 (en) Cynara extract; pharmaceutical composition that contains it; and its use for the treatment of hyperglycemia, hypercholesterolemia, hypertension and hepatic steatosis.
BR112015014078A2 (en) topical ophthalmic pharmaceutical composition containing regorefenib
CY1118277T1 (en) STABLE PHARMACEUTICAL FORM PEXIGANANIS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210528